REMEDi4ALL

Beacon is proud to be working as one of 24 consortium members on a new EU-funded research initiative –REMEDi4ALL.

What is REMEDi4ALL?

REMEDi4ALL (Repurposing of Medicines 4 All) is a EU-backed project which has the goal of driving forward drug purposing initiatives. The ambition is to create an accessible platform that will help guide and educate its users on every and any step involved in the drug repurposing pathway.

REMEDi4ALL plans to:

  • Encourage discussion/skill sharing between different groups involved in drug repurposing e.g. academic researchers, pharmaceutical representatives and policymakers
  • Ensure that patientcentricity is at the heart of all future drug repurposing projects
  • Form a ‘curriculum’ which will help educate anyone and everyone interested in drug repurposing enabling them to effectively take their project to the next level and hopefully to patients!
REMEDi4ALL logo

Beacon’s role in REMEDi4ALL

As a partner within the consortium, Beacon’s role is to:

  • Ensure the principle of patient centric research is maintained throughout the project
  • Help develop and deliver an accessible educational programme to support the international drug repurposing community

Why is REMEDi4ALL important?

Drug repurposing is an innovative way to approach research into some of the world’s most neglected conditions such as rare genetic diseases, infectious diseases and poorly understood cancers.

Drug repurposing offers solutions to many common problems faced in the drug development pathway for rare conditions such as: lack of safety data on a new drug, lack of funding for preclinical research and a lengthy bench to bedside process.

By breaking down barriers and showing drug repurposing to be a viable, patientcentric approach to research, REMEDi4ALL can have a direct impact on patients with rare conditions by bringing costeffective, safe and efficacious medicines to clinic faster.

I support drug repurposing because it can bring treatments to patients faster

Beacon’s REMEDi4ALL team

Rick Thompson

CEO
Rick leads Beacon’s REMEDi4ALL team as well as helping to make crucial decisions relating to the entire project with other key team leaders within the consortium.

Eve Hewitt

Scientific Projects Manager
Eve is responsible for driving patient engagement in drug repurposing projects, as well as educating the repurposing community.

William May

Administrative Officer
Will provides administrative support to Beacon's REMEDi4ALL team and liaises with the wider consortium to ensure our role within the project runs smoothly.

Abby Stock-Duerdoth

Scientific Projects Officer
Abby supports the delivery and development of the repurposing training programme, as well as helping the patient centricity of the project.

Discover more about our team and how to contact them on our meet the team page.